Correlation Between Lineage Cell and Innovent Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lineage Cell and Innovent Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lineage Cell and Innovent Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lineage Cell Therapeutics and Innovent Biologics, you can compare the effects of market volatilities on Lineage Cell and Innovent Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lineage Cell with a short position of Innovent Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lineage Cell and Innovent Biologics.

Diversification Opportunities for Lineage Cell and Innovent Biologics

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Lineage and Innovent is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and Innovent Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovent Biologics and Lineage Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lineage Cell Therapeutics are associated (or correlated) with Innovent Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovent Biologics has no effect on the direction of Lineage Cell i.e., Lineage Cell and Innovent Biologics go up and down completely randomly.

Pair Corralation between Lineage Cell and Innovent Biologics

Given the investment horizon of 90 days Lineage Cell Therapeutics is expected to under-perform the Innovent Biologics. In addition to that, Lineage Cell is 1.76 times more volatile than Innovent Biologics. It trades about -0.15 of its total potential returns per unit of risk. Innovent Biologics is currently generating about -0.02 per unit of volatility. If you would invest  508.00  in Innovent Biologics on August 29, 2024 and sell it today you would lose (23.00) from holding Innovent Biologics or give up 4.53% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Lineage Cell Therapeutics  vs.  Innovent Biologics

 Performance 
       Timeline  
Lineage Cell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lineage Cell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Innovent Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innovent Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Lineage Cell and Innovent Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lineage Cell and Innovent Biologics

The main advantage of trading using opposite Lineage Cell and Innovent Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lineage Cell position performs unexpectedly, Innovent Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovent Biologics will offset losses from the drop in Innovent Biologics' long position.
The idea behind Lineage Cell Therapeutics and Innovent Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals